scholarly journals Pitfalls for diagnosis of burning mouth-like syndrome

2021 ◽  
Vol 67 (3) ◽  
pp. 150-155
Author(s):  
Raluca Ema Pîrvu ◽  
◽  
Ioanina Părlătescu ◽  
Șerban Țovaru ◽  
Cosmin Dugan ◽  
...  
Keyword(s):  
Oral Cavity ◽  
Medical Practice ◽  
Burning Mouth Syndrome ◽  
Diagnostic Approach ◽  
Anxiety And Depression ◽  
Endocrine Disorders ◽  
Systemic Diseases ◽  
Burning Mouth ◽  
Scientific Framework

This research gives a scientific framework for burning mouth syndrome(BMS) etiology and diagnostic approach in clinical dental and medical practice. BMS-like symptoms can be induced by systemic diseases such as diabetes, gastrointestinal, endocrine disorders, allergy etc. or by local oral cavity conditions as candidiasis or geographic tongue or odontogenic causes. Because the etiology of BMS is multifactorial, treatment can only be distinctive, and is aimed at relieving symptoms. The complexity of BMS symptoms and associated psychosocial infirmities, anxiety and depression raise the need for a multidisciplinary and individualised approach.

scholarly journals Burning Mouth Syndrome pada wanita Menopause dengan Hiposalivasi, Coated Tongue dan Gangguan Pengecapan serta Penatalaksanaannya

2012 ◽  
Vol 19 (1) ◽  
pp. 82
Author(s):  
Sri Hadiati
Keyword(s):  
Oral Cavity ◽  
Postmenopausal Women ◽  
Vitamin B1 ◽  
Burning Mouth Syndrome ◽  
Burning Sensation ◽  
Chewing Gum ◽  
Affected Patient ◽  
Burning Mouth ◽  
Oral Burning

Blackground: Burning mouth syndrome (BMS) is a disorder that is characterized by a burning sensation of the oral cavity in the absence of visible local or systemic abnormalities. Affected patient often present with multiple oral complaints, including burning, dryness and taste alterations. The exact cause of burning mouth syndrome often is difficult to pin point. Conditions that have been reported in association with burning mouth syndrome include menopause, hyposlivation, coated tongue, taste alterations and psychologic condition. Objective: To report a case of burning mouth syndrome in postmenopausal women with hyposalivation, coated tongue, taste alterations and psychologic condition and its management. Case and management: a case of burning mouth syndrome in women with menopause, hyposalivation, coated tongue, and taste alterations, was managed effectively by gabapentin 100mg, probiotic chewing gum, diazepam 2mg and vitamin B1, B6, B12. Conclusion: Oral burning appears to be most prevalent in postmenopausal women often present with multiple oral complaints, including burning, dryness and taste alterations, in this case was managed effectively by gabapentin 100mg, prebiotic chewing gum, diazepam 2mg and vitamin B1, B6, B12.

scholarly journals Burning mouth syndrome caused by xerostomia secondary to amlodipine

2020 ◽  
Vol 53 (4) ◽  
pp. 187
Author(s):  
Tengku Natasha Eleena Binti Tengku Ahmad Noor
Keyword(s):  
Oral Cavity ◽  
Oral Hygiene ◽  
Health Care Professionals ◽  
Adverse Drug Events ◽  
Burning Mouth Syndrome ◽  
Burning Sensation ◽  
Dry Mouth ◽  
Protective Function ◽  
Burning Mouth ◽  
Oral Hygiene Instructions

Background: Xerostomia, generally referred to as dry mouth, has been identified as a side effect of more than 1,800 drugs from more than 80 groups. This condition is frequently unrecognised and untreated but may affect patients’ quality of life and cause problems with oral and medical health, including burning mouth syndrome (BMS). Purpose: The purpose of this case is to discuss how to manage a patient with BMS caused by xerostomia secondary to medication that has been taken by the patient. Case: We reported that a 45-year-old male military officer from the Royal Malaysian Air Force came to Kuching Armed Forces Dental Clinic with dry mouth and a burning sensation since he started taking 10 mg of amlodipine due to his hypertension. After a thorough physical and history examination, we made a diagnosis of burning mouth syndrome (BMS) caused by xerostomia secondary to amlodipine. Case Management: Oral hygiene instructions, diet advice and prescription of Oral7 mouthwash has been given to reduce the symptoms of BMS. The patient has been referred to the general practitioner to reduce his amlodipine dosage from 10 mg to 5 mg (OD) in order to prevent xerostomia, and oral hygiene instructions have been given. A review after two weeks showed significant changes in the oral cavity, and the patient was satisfied as he is no longer feeling the burning sensation and can enjoy his food without feeling difficulty in chewing and swallowing. Conclusion: Adverse drug events are normal in the oral cavity and may have a number of clinical presentations such as xerostomia. Xerostomia can cause many implications as saliva helps in maintaining oral mucosa and has a protective function. The signs of adverse drug incidents in the oral cavity should be identified to oral health care professionals.

Role of psychological factors in burning mouth syndrome: A systematic review and meta-analysis

Cephalalgia ◽  
2016 ◽  
Vol 37 (3) ◽  
pp. 265-277 ◽  
Author(s):  
Federica Galli ◽  
Giovanni Lodi ◽  
Andrea Sardella ◽  
Elena Vegni
Keyword(s):  
Systematic Review ◽  
Psychological Factors ◽  
Medical Condition ◽  
Meta Analysis ◽  
Burning Mouth Syndrome ◽  
Chronic Medical Condition ◽  
Anxiety And Depression ◽  
Personality Factors ◽  
Burning Mouth

Background Burning mouth syndrome (BMS) is a chronic medical condition characterised by hot, painful sensations in the lips, oral mucosa, and/or tongue mucosa. On examination, these appear healthy, and organic causes for the pain cannot be found. Several studies have yielded scant evidence of the involvement of psychological and/or psychopathological factors, and several have outlined a model for the classification of BMS. Aim This review aims to provide a systematic review of research examining the psychological, psychiatric, and/or personality factors linked to BMS. Findings Fourteen controlled studies conducted between 2000 and the present were selected based on stringent inclusion/exclusion criteria. All studies but one reported at least some evidence for the involvement of psychological factors in BMS. Anxiety and depression were the most common and the most frequently studied psychopathological disorders among BMS patients. Discussion and conclusion Anxiety and depression play critical roles in this condition. Evidence on the role of personality characteristics of BMS patients has also been produced by a few studies. Further studies on the role of specific psychological factors in BMS are warranted, but the importance of a multidisciplinary approach (medical and psychological) to BMS is no matter of discussion.

scholarly journals Evaluating the Suitability and Potential Efficiency of Cannabis sativa Oil for Patients with Primary Burning Mouth Syndrome: A Prospective, Open-Label, Single-Arm Pilot Study

Pain Medicine ◽  
2020 ◽  
Author(s):  
Alessio Gambino ◽  
Marco Cabras ◽  
Evangelos Panagiotakos ◽  
Federico Calvo ◽  
Alessandra Macciotta ◽  
...  
Keyword(s):  
Pilot Study ◽  
Adverse Events ◽  
Pain Intensity ◽  
Cannabis Sativa ◽  
Burning Mouth Syndrome ◽  
Anxiety And Depression ◽  
Mcgill Pain Questionnaire ◽  
Placebo Control ◽  
Open Label ◽  
Burning Mouth

Abstract Objective To evaluate the use of a Cannabis sativa oil in the management of patients diagnosed with primary burning mouth syndrome (BMS). Design Prospective, open-label, single-arm pilot study. Setting University hospital. Subjects Seventeen patients with diagnosed BMS were included. Methods Subjects were treated for 4 weeks with a full cannabis plant extract, which was prepared from standardized plant material (cannabis flos) in specialized pharmacies by means of Romano-Hazekamp extraction and was diluted in oil (1 g of cannabis in 10 g of olive oil). The primary outcome was the change in pain intensity (assessed by the visual analog scale, Present Pain Intensity scale, McGill Pain Questionnaire, and Oral Health Impact Profiles) at the end of the protocol and during the succeeding 24 weeks; the neuropathic pain was also investigated with a specific interview questionnaire (DN4-interview [Douleur Neuropathique en 4 Questions]). Levels of anxiety and depression were considered as secondary outcomes, together with reported adverse events due to the specified treatment. Results Subjects showed a statistically significant improvement over time in terms of a clinical remission of the oral symptoms. Levels of anxiety and depression also changed statistically, displaying a favorable improvement. No serious reactions were detailed. None of the patients had to stop the treatment due to adverse events. Conclusions In this pilot evaluation, the C. sativa oil provided was effective and well tolerated in patients with primary BMS. Further bigger and properly defined randomized controlled trials, with different therapeutic approaches or placebo control, are needed, however.

scholarly journals Suicidal Behavior in a Patient with Burning Mouth Syndrome

2014 ◽  
Vol 2014 ◽  
pp. 1-3
Author(s):  
Konstantinos Kontoangelos ◽  
Evmorfia Koukia ◽  
Vasilis Papanikolaou ◽  
Aris Chrysovergis ◽  
Antonis Maillis ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Oral Cavity ◽  
Psychiatric Comorbidity ◽  
Burning Mouth Syndrome ◽  
Burning Sensation ◽  
Multiple Forms ◽  
Case Presentation ◽  
Local Pain ◽  
Burning Mouth

Introduction. Chronic pain of the oral cavity is a long-term condition and like all other types of chronic pain is associated with numerous comorbidities such as depression or anxiety.Case Presentation. This is a case of a 93-year-old patient suffering from chronic oral cavity pain who repeatedly stabbed his palate due to ongoing local pain, over the last few months, which he could not further tolerate. The patient was suffering from depression and also a diagnosis of “burning mouth syndrome” (BMS) was made.Discussion. Burning mouth syndrome (BMS) is characterized by a burning sensation in the tongue or other oral sites. BMS has high psychiatric comorbidity but can occur in the absence of psychiatric diagnosis. Patients with multiple forms of pain must be considered as potential candidates for underdiagnosed depression (major) and suicidal thoughts.

scholarly journals Assessment of anxiety and depression in patients with burning mouth syndrome: A clinical trial

2012 ◽  
Vol 3 (1) ◽  
pp. 36
Author(s):  
Rohit Malik ◽  
Deepankar Misra ◽  
Akansha Misra ◽  
Sapna Panjwani ◽  
Sumit Goel
Keyword(s):  
Clinical Trial ◽  
Burning Mouth Syndrome ◽  
Anxiety And Depression ◽  
Burning Mouth

scholarly journals Burning mouth syndrome (BMS) – clinical symptoms

ORL ro ◽  
2021 ◽  
Vol 3 (1) ◽  
pp. 34-36 ◽  
Author(s):  
Elena Claudia Coculescu ◽  
Bogdan-Ioan Coculescu
Keyword(s):  
Medical Practice ◽  
Clinical Symptoms ◽  
Burning Mouth Syndrome ◽  
Dental Disease ◽  
Know How ◽  
Secondary Form ◽  
Burning Mouth ◽  
Attending Physician

The scientific news and the importance for medical practice of approaching this oro-dental disease is supported not only by the patient’s persistent long-term suffering, but also by the concern to know how to identify the possible etiopathogenesis, especially in the secondary form, which once identified and sanctioned therapeutically is successful for both the attending physician and the patient.  

Burning mouth syndrome in menopausal women

2021 ◽  
Vol 26 (4) ◽  
pp. 39-45
Author(s):  
M. Yu. Maksimova ◽  
S. N. Illarioshkin ◽  
N. A. Sineva
Keyword(s):  
Quality Of Life ◽  
Oral Health ◽  
Oral Cavity ◽  
Rating Scale ◽  
Burning Mouth Syndrome ◽  
Life Assessment ◽  
Menopausal Women ◽  
Burning Mouth ◽  
The Impact

Many women in menopause experience discomfort in the oral cavity — burning, dysesthesia, xerostomia, taste changes, which lead to a reduction in the quality of life.Aim: to identify clinical and psychological factors associated with the development of burning mouth syndrome in menopausal women.Material and methods. Were examined 67 women aged 45–67 years. Assessment of oral pain performed using the Visual analog scale (VAS). Assessment of dry mouth symptoms severity performed using the Challacombe Scale of Clinical Oral Dryness (CSCOD). Psychometric tests was carried out with Spielberger’s Anxiety Test, Montgomery–Asberg Depression Rating Scale (MADRS), Hospital Anxiety and Depression Scale (HADS), Mini-Mental State Examination (MMSE). The Psychological stress measure-25 scale was also used to assess the impact of stress on somatic, behavioral, and emotional indicators of life. The quality of life was measured using the Oral Health Impact Profile-14 (OHIP-14).Results. Clinically, burning mouth syndrome in menopausal women manifested with various oral symptoms include paresthesias and pain in the tongue, oral cavity, as well as xerostomia and taste disorders. Painful sensations in the tongue developed 1–3 years after the menopause onset and was preceded by stressful life events. The pain scores on the VAS was 63.1 ± 11.8 mm. Depressive disorders were characterized by an average level of personal and situational anxiety, instability to stressful influences. The quality of life assessment in menopausal women using the OHIP-14 scale, the total score was 17.1 ± 5.21 points and corresponded to the sufficient quality of oral health.Conclusion. Burning mouth syndrome and neuropsychiatric disorders (anxiety, asthenia, depression, phobia, sleep disorders) in menopausal women are pathophysiologically related conditions.

Burning Mouth Syndrome after Taking Clonazepam

2001 ◽  
Vol 35 (7-8) ◽  
pp. 874-876 ◽  
Author(s):  
Nicole S Culhane ◽  
Audrey D Hodle
Keyword(s):  
Clinical Presentation ◽  
Burning Mouth Syndrome ◽  
Burning Sensation ◽  
Anxiety And Depression ◽  
Probability Scale ◽  
Case Summary ◽  
Published Report ◽  
Underlying Causes ◽  
Burning Mouth ◽  
Oral Burning

OBJECTIVE: To report the first published case of clonazepam-induced burning mouth syndrome (BMS). CASE SUMMARY: A 52-year-old white woman presented to the clinic with burning mouth symptoms. The patient was previously maintained on alprazolam therapy for anxiety, but was switched to clonazepam because of increased anxiety and panic. Clonazepam significantly relieved her symptoms, but after four weeks of therapy, she reported a constant, mild, oral burning sensation. An oral examination was negative for mucosal abnormalities, and laboratory tests were unremarkable. The clonazepam dose was reduced, and the symptoms decreased, but remained intolerable. Clonazepam was discontinued, and the burning mouth symptoms completely resolved. Since no other medications relieved the anxiety and panic symptoms, the patient requested clonazepam to be reinitiated, but she again developed intolerable burning mouth symptoms. As clonazepam was discontinued, the symptoms resolved. DISCUSSION: The clinical presentation of BMS includes burning and painful sensations of the mouth in the absence of mucosal abnormalities. Candidiasis, anemia, menopause, diabetes mellitus, medications, anxiety, and depression are some causes of this syndrome. Paradoxically, clonazepam has been studied for the treatment of BMS and has demonstrated mild to moderate improvement. In this patient, underlying causes of BMS were eliminated when possible. The association between clonazepam and BMS was highly probable according to the Naranjo probability scale. CONCLUSIONS: This is the first published report describing BMS with a benzodiazepine. Although uncommon, clinicians should be aware of this potential adverse effect due to the widespread use of benzodiazepines.

Sign in / Sign up

Export Citation Format

Share Document